Article
Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations.
The Journal of steroid biochemistry and molecular biology - 1 Jul 2013
Zhang Qiuhong, Kanterewicz Beatriz, Shoemaker Suzanne, Hu Qiang, Liu Song, Atwood Kristopher, Hershberger Pamela
Abstract excerpt
We previously demonstrated that non-small cell lung cancer (NSCLC) cells and primary human lung tumors aberrantly express the vitamin D3-catabolizing enzyme, CYP24, and that CYP24 restricts transcriptional regulation and growth control by 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) in NSCLC cells. To ascertain the basis for CYP24 dysregulation, we assembled a panel of cell lines that represent distinct molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
